"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
| Descriptor ID |
D018426
|
| MeSH Number(s) |
E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
|
| Concept/Terms |
SEER Program- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
|
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 5 | 7 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 5 | 5 |
| 2010 | 2 | 4 | 6 |
| 2011 | 0 | 7 | 7 |
| 2012 | 3 | 10 | 13 |
| 2013 | 2 | 8 | 10 |
| 2014 | 3 | 8 | 11 |
| 2015 | 0 | 7 | 7 |
| 2016 | 1 | 6 | 7 |
| 2017 | 0 | 5 | 5 |
| 2018 | 0 | 6 | 6 |
| 2019 | 1 | 14 | 15 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 2 | 3 |
| 2024 | 5 | 2 | 7 |
| 2025 | 0 | 5 | 5 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
-
Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study. Cancer Causes Control. 2026 Jan 21; 37(2):33.
-
Neighborhood socioeconomic status and endometrial cancer mortality: Racial disparities persist across the spectrum. Gynecol Oncol. 2025 Dec; 203:84-89.
-
Incidence, Tumor Characteristics, and Prognostic Factors of Dermal and Subcutaneous Leiomyosarcoma of the Skin: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results Database. Dermatol Surg. 2026 Feb 01; 52(2):101-107.
-
Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US. Br J Cancer. 2025 Aug; 133(2):248-254.
-
Incidence and Survival of Children and Adolescents With Wilms Tumor, United States, 2001-2020. Cancer Med. 2025 Feb; 14(3):e70598.
-
Occult metastases and survival of lung cancer by clinical diagnosis and CT screening: A simulation study. PLoS One. 2025; 20(1):e0313544.
-
Pediatric sporadic Burkitt lymphoma of the head and neck: A case series and analysis of national trends. Int J Pediatr Otorhinolaryngol. 2024 Nov; 186:112137.
-
Epidemiology of dermatofibrosarcoma protuberans among Asian-American sub-groups: a population-based study of the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol Res. 2024 Sep 26; 316(9):637.
-
Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071.
-
The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population? Thyroid. 2024 09; 34(9):1117-1125.